The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists.
作者信息
Ferrario Alessandra, Orubu Ebiowei Samuel F, Adeyeye Moji Christianah, Zaman Muhammad H, Wirtz Veronika J
机构信息
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, United States of America.
Institute for Health System Innovation and Policy, Boston University, Boston, Massachusetts, United States of America.
出版信息
BMJ Glob Health. 2019 Jul 18;4(4):e001681. doi: 10.1136/bmjgh-2019-001681. eCollection 2019.
Abstract
摘要
相似文献
1
The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists.
BMJ Glob Health. 2019 Jul 18;4(4):e001681. doi: 10.1136/bmjgh-2019-001681. eCollection 2019.
2
Fighting trafficking of falsified and substandard medicinal products in Russia.
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
3
Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
PLoS One. 2017 Sep 6;12(9):e0184165. doi: 10.1371/journal.pone.0184165. eCollection 2017.
4
Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea.
BMJ Glob Health. 2017 Oct 15;2(4):e000409. doi: 10.1136/bmjgh-2017-000409. eCollection 2017.
5
Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Ethiop J Health Sci. 2016 May;26(3):259-76. doi: 10.4314/ejhs.v26i3.9.
6
When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.
J Public Health Policy. 2013 Jan;34(1):22-30. doi: 10.1057/jphp.2012.53. Epub 2012 Nov 22.
7
Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
Health Policy Plan. 2016 Dec;31(10):1448-1466. doi: 10.1093/heapol/czw062. Epub 2016 Jun 16.
8
Legal aspects of counteracting the trafficking of falsified medicines in the european union.
Wiad Lek. 2017;70(4):843-849.
9
Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
J Public Health Policy. 2015 Nov;36(4):384-9. doi: 10.1057/jphp.2015.22. Epub 2015 Jul 16.
10
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists.
Eur J Hosp Pharm. 2018 Jan;25(1):10-15. doi: 10.1136/ejhpharm-2016-000970. Epub 2016 Jul 27.
引用本文的文献
1
The challenges associated with the prevention of smuggling and counterfeiting health goods in Iran.
BMC Public Health. 2024 Jun 11;24(1):1564. doi: 10.1186/s12889-024-18637-0.
2
Exploring pharmacists' perspectives about substandard and falsified medical products through interviews.
Explor Res Clin Soc Pharm. 2024 Feb 14;13:100421. doi: 10.1016/j.rcsop.2024.100421. eCollection 2024 Mar.
3
Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs.
Ann Med Surg (Lond). 2023 Feb 7;85(2):122-123. doi: 10.1097/MS9.0000000000000113. eCollection 2023 Feb.
4
Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa.
BMJ Glob Health. 2023 Feb;6(Suppl 3). doi: 10.1136/bmjgh-2022-009367.
5
A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.
J Med Access. 2022 Feb 15;6:23992026221074548. doi: 10.1177/23992026221074548. eCollection 2022 Jan-Dec.
6
Evaluation of pharmacists' awareness of illegal online pharmacies and perceived impact on safe access to medicines.
Med Access Point Care. 2021 Apr 18;5:23992026211005642. doi: 10.1177/23992026211005642. eCollection 2021 Jan-Dec.
7
Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis.
Sci Rep. 2021 Jun 9;11(1):12145. doi: 10.1038/s41598-021-91443-5.
8
Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet.
Am Health Drug Benefits. 2021 Mar;14(1):22-28.
9
The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations.
Antibiotics (Basel). 2020 Dec 14;9(12):904. doi: 10.3390/antibiotics9120904.
本文引用的文献
1
Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.
Wellcome Open Res. 2019 Apr 16;4:70. doi: 10.12688/wellcomeopenres.15236.1. eCollection 2019.
2
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2018 Aug 3;1(4):e181662. doi: 10.1001/jamanetworkopen.2018.1662.
3
A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs.
PLoS One. 2018 Aug 28;13(8):e0203185. doi: 10.1371/journal.pone.0203185. eCollection 2018.
4
Fake medicines: fighting on all fronts.
Lancet Respir Med. 2018 May;6(5):315. doi: 10.1016/S2213-2600(18)30152-8. Epub 2018 Apr 10.
5
Oncology drugs in the crosshairs of pharmaceutical crime.
Lancet Oncol. 2018 Apr;19(4):e209-e217. doi: 10.1016/S1470-2045(18)30101-3.
6
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy.
J Pharm Policy Pract. 2016 Nov 10;9:36. doi: 10.1186/s40545-016-0088-0. eCollection 2016.
7
Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
Health Policy Plan. 2016 Dec;31(10):1448-1466. doi: 10.1093/heapol/czw062. Epub 2016 Jun 16.
8
Substandard/counterfeit antimicrobial drugs.
Clin Microbiol Rev. 2015 Apr;28(2):443-64. doi: 10.1128/CMR.00072-14.
9
Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.
Malar J. 2014 Apr 8;13:139. doi: 10.1186/1475-2875-13-139.
Zotero 插件